Recent #Artificial Intelligence #Gadgets  startups have struggled to convert hype to usable gadgets. But one private-market tech company is not having a hard time driving revenue. It’s Oura, best known for its wearable rings. Bloomberg reports that Oura’s revenues are nearing the $500 million annual mark. That’s plenty big enough to go public, even if the company — sadly — doesn’t seem to be in much of a hurry to drop its startup tag.

https://www.bloomberg.com/news/articles/2024-09-30/oura-nears-500-million-in-annual-revenue-and-readies-new-ring

 #Biohackers Connect

Oura Nears $500 Million in Annual Revenue and Readies New Ring

Artificial Intelligence

Gadgets

Biohackers Connect

Recent #Artificial Intelligence #Gadgets  startups have struggled to convert hype to usable gadgets. But one private-market tech company is not having a hard time driving revenue. It’s Oura, best known for its wearable rings. Bloomberg reports that Oura’s revenues are nearing the $500 million annual mark. That’s plenty big enough to go public, even if the company — sadly — doesn’t seem to be in much of a hurry to drop its startup tag.  https://www.bloomberg.com/news/articles/2024-09-30/oura-nears-500-million-in-annual-revenue-and-readies-new-ring   #Biohackers Connect

Sam Mendoza

https://www.ft.com/content/48a9d56d-73e5-448a-8254-8aaa02954270

Oura hits $5B valuation: Smart ring maker Oura has raised $75M in Series D funding from glucose monitoring giant Dexcom, boosting its valuation to over $5B. The partnership will integrate Dexcom's glucose data with Oura's health metrics, enabling users to track the impact of nutrition on their health, with the first app integration set for 2025. Oura, which has sold 2.5M rings and expects $500M in sales next year, is now competing with Apple's efforts in noninvasive glucose tracking.

https://techcrunch.com/2024/11/19/oura-valued-at-5b-following-deal-with-medical-device-firm-dexcom/

 #Gadgets

Oura hits $5B valuation: Smart ring maker Oura has raised $75M in Series D funding from glucose monitoring giant Dexcom, boosting its valuation to over $5B. The partnership will integrate Dexcom's glucose data with Oura's health metrics, enabling users to track the impact of nutrition on their health, with the first app integration set for 2025. Oura, which has sold 2.5M rings and expects $500M in sales next year, is now competing with Apple's efforts in noninvasive glucose tracking.  https://techcrunch.com/2024/11/19/oura-valued-at-5b-following-deal-with-medical-device-firm-dexcom/   #Gadgets

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.

Oura valued at $5B following deal with medical device firm Dexcom | TechCrunch

Jerome Cody

Finnish company’s growing popularity has led to its sales more than doubling this year

Smart ring start-up Ōura raises $200mn as valuation leaps to $5.2bn

Bobby

The reason Oura is successful is because people usually don’t like wearing watches to bed!

70 bucks a year subscription on top of a $349 purchase is nuts when an Apple Watch SE which runs around $170 (or myriad other smartwatches) will do most of the same job for free. I understand paying a premium for the tech but fail to see how the data collection/analysis is worth it.

Sam Mendoza

A group of likeminded people in Biohackers Connect are talking about this.